Market Place
Sourcing Support
Remedy Pharmaceuticals` Phase 3 Stroke Trial Shows Significant Effect
01 Oct 2024 //
PR NEWSWIRE
Remedy Gets Acute Stroke Drug Back Shows Positive Subgroup Analysis
30 May 2024 //
PR NEWSWIRE
Generic Drugmaker Admits to Price Fixing
01 Jun 2019 //
RAPS
Cadila`s Generic Glyburide Receives Approval in US
07 Jan 2019 //
FDA
Ammtek`s Amglidia (glibenclamide) Receives Approval In Europe
09 Jun 2018 //
EMA
EMA recommends authorisation to Amglidia for neonatal diabetes
27 Feb 2018 //
EMA
EMA committee recommends approval for Amglidia to treat neonatal diabetes
26 Feb 2018 //
PHARMABIZ
Five new medicines backed for EU approval
26 Feb 2018 //
PHARMA TIMES
EMA’s CHMP Recommends Five New Medicines for Approval
26 Feb 2018 //
RAPS
Five medicines recommended for approval, including two orphans
23 Feb 2018 //
EMA
Biogen reveals Tysabri failure in stroke trial
09 Feb 2018 //
PHARMA TIMES
Golfing, ‘girls night out’ where pharma employees allegedly fixed prices
23 Dec 2016 //
STAT
Sun Pharma most at Risk in US Probe
21 Dec 2016 //
FINANCIAL EXPRESS
Price Fixing Lawsuit Slapped Against Aurobindo, Mylan, Others in US
17 Dec 2016 //
FINANCIAL EXPRESS
The Man The Feds Are Using To First Crack Open Their Big Antitrust Case
15 Dec 2016 //
FORBES
Evaluation of glibenclamide microspheres for sustained release
16 Nov 2016 //
PHARMA EXCIPIENTS
Zydus Cadila gets USFDA nod to sell generic diabetes drug
10 May 2016 //
ECONOMIC TIMES
Comparative evaluation of porous silica based carriers for lipids and liquid drug formulations
03 Mar 2016 //
PHARMAEXCIPIENTS
Zydus Cadila gets USFDA nod for anti-diabetics tablets
29 Feb 2016 //
BUSINESS STANDARD
Impax Lab gets US FDA approval for generic glyburide tablets
07 Oct 2015 //
PHARMABIZ
Corepharma`s Generic Glyburide approved in US for Type 2 diabetes
30 Sep 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.